Be part of the knowledge.™
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ACC Action Center

PCSK9i Reduces Plaque Burden in Coronary Arteries 

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments

  • Overview

    Dr. Lorenz Raber recaps the PACMAN-AMI study and how the PCSK9 inhibitor alirocumab can aid in coronary plaque regression. 

Recommended
Details
Comments

  • Overview

    Dr. Lorenz Raber recaps the PACMAN-AMI study and how the PCSK9 inhibitor alirocumab can aid in coronary plaque regression. 

Schedule23 Oct 2024
PrevNext

Program Chapters

Segment Chapters

Playlist:

Recommended